Wolf Popper LLP

Recent News

Twitter Inc. Lead Plaintiff Deadline Alert: Wolf Popper LLP Reminds Twitter Investors of June 13, 2022 Deadline to Seek Appointment as Lead Plaintiff in Class Action

New York, New York--(Newsfile Corp. - April 19, 2022) - Wolf Popper LLP reminds investors who sold Twitter, Inc. common stock (NYSE: TWTR) between March 24, 2022 and April 1, 2022 (Class Period) that they have until June 13, 2022 to seek appointment as lead plaintiff in the securities class action lawsuit against Elon Musk pending in the U.S. District Court for the Southern District of New York.The class action alleges that Mr. Musk acquired a 5% ownership stake in...

2022-04-19 7:00 AM EDT

Wolf Popper LLP Announces Investigation into Potential Securities Fraud By Elon Musk on Behalf of Sellers of Twitter, Inc. Common Stock

New York, New York--(Newsfile Corp. - April 14, 2022) - Wolf Popper LLP is investigating potential securities fraud claims against Elon Musk on behalf of sellers of Twitter, Inc. common stock (NYSE: TWTR) related to whether Mr. Musk violated U.S. Securities and Exchange Commission (SEC) regulations by failing to disclose that he had acquired a 5% ownership stake in Twitter. According to Mr. Musk's SEC filings, he appears to have acquired a 5% ownership stake in Twitter on March...

2022-04-14 8:20 AM EDT

Wolf Popper LLP Announces Investigation on Behalf of Investors in Volta Inc

New York, New York--(Newsfile Corp. - March 29, 2022) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Volta Inc. common stock (NYSE: VLTA).In February 2021, Tortoise Acquisition Corp. II (NYSE: SNPR), a special purpose acquisition company, announced it would combine with Volta Industries, Inc. in a $2 billion deal.The merger was approved by a majority vote of the holders of Tortoise common shares. The merger closed on August 26, 2021 and...

2022-03-29 12:43 PM EDT

Wolf Popper LLP Is Investigating Astra Space, Inc. For Potential Breaches of Fiduciary Duty

New York, New York--(Newsfile Corp. - March 23, 2022) - Wolf Popper LLP is investigating claims on behalf of investors in Astra Space, Inc. (NASDAQ: ASTR) concerning Astra's merger with the special purpose acquisition company (or "SPAC") Holicity Inc. and who held Astra/Holicity shares continuously since June 28, 2021, or who sold their Astra shares after June 28, 2021, for less than the $10.00 per-share redemption amount.On February 2, 2021, Holicity announced it was going to merge with...

2022-03-23 8:00 AM EDT

Wolf Popper LLP Reminds Gatos Silver, Inc. Investors of April 25, 2022 Lead Plaintiff Deadline

New York, New York--(Newsfile Corp. - March 10, 2022) - Wolf Popper LLP announces that a class action lawsuit has been filed on behalf of purchasers of Gatos Silver, Inc. (NYSE: GATO) securities in the U.S. District Court for the District of Colorado. Investors who purchased (a) Gatos Silver common stock pursuant and/or traceable to the Registration Statement issued in connection with Gatos Silver's initial public offering ("IPO") conducted on or about October 28, 2020; and/or (b) Gatos...

2022-03-10 8:00 AM EST

Wolf Popper LLP Announces Investigation on Behalf of Investors in Gatos Silver, Inc.

New York, New York--(Newsfile Corp. - January 26, 2022) - Wolf Popper LLP is investigating potential securities claims on behalf of purchasers of Gatos Silver, Inc. ("Gatos") common stock (NYSE: GATO).Gatos is predominantly a silver exploration, development and production mining company with operations in Mexico. Gatos owns a 70% stake in the Los Gatos Joint Venture (LGJV). Gatos's two projects include the Cerro Los Gatos mine (CLG) and the Los Gatos District which is comprised of over a...

2022-01-26 2:39 PM EST

Wolf Popper LLP Investigates the Proposed Merger of Lawson Products, Inc. with TestEquity & Gexpro Services

New York, New York--(Newsfile Corp. - January 5, 2022) - Wolf Popper LLP is investigating claims on behalf of investors in Lawson Products, Inc. (NASDAQ: LAWS) concerning the proposed merger of Lawson with TestEquity and Gexpro Services. Lawson's controlling shareholder is Luther King Capital Management Corporation ("LKCM Corp."), which owns approximately 48% of Lawson's shares. LKCM Corp. has a private investment arm called LKCM Headwater Investments (Headwater) which owns TestEquity and...

2022-01-05 9:32 AM EST

Wolf Popper LLP Investigates the Proposed Acquisition of StarTek, Inc. by CSP Management Limited

New York, New York--(Newsfile Corp. - January 5, 2022) - Wolf Popper LLP is investigating claims on behalf of investors in StarTek, Inc. (NYSE: SRT) concerning the proposed acquisition of StarTek by CSP Management Limited, which owns approximately 55.3% of the issued and outstanding StarTek common shares. Under the terms of the proposed acquisition, StarTek shareholders would receive $5.40 for each share of common stock they hold, which is below StarTek's 52-week average and high stock prices...

2022-01-05 8:49 AM EST

Wolf Popper LLP Announces Investigation on Behalf of Investors in IronNet, Inc.

New York, New York--(Newsfile Corp. - December 20, 2021) - Wolf Popper LLP is investigating potential securities claims on behalf of purchasers of IronNet, Inc. ("IronNet") common stock (NYSE: IRNT). IronNet offers cybersecurity solutions through its Collective Defense platform.On March 15, 2021, LGL Systems Acquisition Corp. ("LGL") (NYSE: DFNS), a special purpose acquisition company, announced it would combine with IronNet Cybersecurity, Inc. (a predecessor to IronNet, referred to...

2021-12-20 8:00 AM EST

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Reata Pharmaceuticals, Inc. (RETA) Common Stock

New York, New York--(Newsfile Corp. - December 7, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) common stock.Reata is a clinical-stage drug company. Reata's lead program is developing the drug bardoxolone methyl for the treatment of chronic kidney disease caused by Alport syndrome ("AS"). In August 2017, Reata announced it enrolled the first patient in the Phase 3 portion of its CARDINAL trial...

2021-12-07 11:03 AM EST

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of CareDx, Inc. (CDNA) Common Stock

New York, New York--(Newsfile Corp. - October 29, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of CareDx, Inc. (NASDAQ: CDNA) common stock.CareDx develops and commercializes diagnostic solutions for transplant patients. After the market closed on October 28, 2021, CareDx announced strong third quarter 2021 results and increased its 2021 fiscal year revenue guidance. However, CareDx's third quarter 2021 Form 10-Q disclosed that CareDx had...

2021-10-29 3:49 PM EDT

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Novavax, Inc. (NVAX) Common Stock

New York, New York--(Newsfile Corp. - October 20, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Novavax, Inc. (NASDAQ: NVAX) common stock.Novavax is a clinical-stage drug company that has been developing NVX-CoV2373, its COVID-19 vaccine. On July 7, 2021, Novavax announced it had been selected to participate in Operation Warp Speed and was awarded $1.6 billion by the federal government to complete late-stage clinical development,...

2021-10-20 12:28 PM EDT

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Eargo, Inc. (EAR) Common Stock

New York, New York--(Newsfile Corp. - September 23, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Eargo, Inc. (NASDAQ: EAR) common stock.Eargo, Inc. designs and markets hearing aids that cost up to $2,500. Eargo went public when it held its Initial Public Offering on October 15, 2020 at $18.00 per share.After the market closed on September 22, 2021, Eargo disclosed "…it is the target of a criminal investigation by the U.S....

2021-09-23 8:45 AM EDT

Wolf Popper LLP Reminds Zymergen Inc. (ZY) Investors of October 4, 2021 Lead Plaintiff Filing Deadline

New York, New York--(Newsfile Corp. - September 23, 2021) - Wolf Popper LLP announces that a that federal securities class action lawsuit has been filed in the U.S. District Court for the Northern District of California against Zymergen Inc. and certain of its officers, directors, and underwriters for its April 2021 initial public offering (IPO). The class action is brought on behalf of investors who purchased or otherwise acquired Zymergen common stock (NASDAQ: ZY) pursuant and/or traceable...

2021-09-23 8:39 AM EDT

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Berkeley Lights, Inc. (BLI) Common Stock

New York, New York--(Newsfile Corp. - September 15, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Berkeley Lights, Inc. (NASDAQ: BLI) common stock.Berkeley Lights is a digital cell biology company that focuses on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products. Berkeley Lights sells several machines that are used in a medical setting to perform various functions on...

2021-09-15 5:05 PM EDT

Wolf Popper LLP Reminds View, Inc. (VIEW) Investors of October 17, 2021 Lead Plaintiff Filing Deadline

New York, New York--(Newsfile Corp. - August 25, 2021) - Wolf Popper LLP reminds View, Inc. (NASDAQ: VIEW) f/k/a CF Finance Acquisition Corp. II (NASDAQ: CFII) investors that a federal securities class action lawsuit has been filed in the U.S. District Court for the Northern District of California against View and certain of View's officers. The deadline for View investors to seek appointment as the lead plaintiff in the lawsuit is October 18, 2021.The securities class action is brought...

2021-08-25 10:03 AM EDT

Wolf Popper LLP Reminds Athira Pharma, Inc. (ATHA) Investors of August 24, 2021 Lead Plaintiff Filing Deadline

New York, New York--(Newsfile Corp. - August 16, 2021) - Wolf Popper LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) investors that federal securities class action lawsuits have been filed in the U.S. District Court for the Western District of Washington against Athira Pharma and certain of its officers, directors, and IPO underwriters. The deadline for Athira investors to seek appointment as the lead plaintiff in the lawsuits is August 24, 2021.The securities class actions are brought on...

2021-08-16 7:00 AM EDT

Wolf Popper LLP Reminds DiDi Global, Inc. (DIDI) Investors of September 7, 2021 Lead Plaintiff Filing Deadline

New York, New York--(Newsfile Corp. - August 16, 2021) - Wolf Popper LLP reminds DiDi Global, Inc. (NYSE: DIDI) investors that federal securities class action lawsuits have been filed in the United States District Courts for the Central District of California and Southern District of New York against DiDi and certain of DiDi's officers, directors, and IPO underwriters. The deadline for DiDi investors to seek appointment as the lead plaintiff in the securities class actions is September 7,...

2021-08-16 7:00 AM EDT

Wolf Popper LLP Announces Investigation on Behalf of Investors in AppHarvest, Inc.

New York, New York--(Newsfile Corp. - August 12, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of AppHarvest, Inc. common stock (NASDAQ: APPH).On February 1, 2021, AppHarvest, Inc. (which at the time was a private company) merged into Novus Capital Corporation (NASDAQ: NOVS), a special purpose acquisition company. Pursuant to that merger, Novus changed its name to AppHarvest and began trading under the stock symbol APPH. The press release...

2021-08-12 9:20 AM EDT

Wolf Popper LLP Announces Investigation on Behalf of Purchasers of Zymergen Inc. (ZY) Common Stock

New York, New York--(Newsfile Corp. - August 4, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Zymergen Inc. common stock (NASDAQ: ZY).Zymergen purports to design, develop, and commercialize breakthrough products faster, cheaper, and greener than before through what the company calls biofacturing. Zymergen held its initial public offering on April 21, 2021 and sold 18.54 million shares at $31.00 per share.Wolf Popper's investigation is...

2021-08-04 10:22 AM EDT

Ready to Announce with Confidence?

Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

Contact Us